Am J Perinatol 2024; 41(08): 1062-1068
DOI: 10.1055/a-1786-8688
Original Article

Bleeding Complications in Neonates Receiving Extracorporeal Membrane Oxygenation and Controlled Hypothermia

1   Department of Pediatrics, Drexel University College of Medicine Philadelphia, Pennsylvania
2   Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
3   Division of Extracorporeal Membrane Support, Department of Pediatrics, Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
,
Vilmaris Quinones Cardona
1   Department of Pediatrics, Drexel University College of Medicine Philadelphia, Pennsylvania
2   Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
3   Division of Extracorporeal Membrane Support, Department of Pediatrics, Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
,
Erica Poletto
1   Department of Pediatrics, Drexel University College of Medicine Philadelphia, Pennsylvania
4   Division of Radiology, Department of Pediatrics, Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
,
Ogechukwu Menkiti
1   Department of Pediatrics, Drexel University College of Medicine Philadelphia, Pennsylvania
2   Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
3   Division of Extracorporeal Membrane Support, Department of Pediatrics, Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
› Institutsangaben

Funding None.
Preview

Abstract

Objective Safety and efficacy data on controlled hypothermia (CH) for neonates with moderate to severe hypoxic ischemic encephalopathy has been extrapolated to a subgroup of these patients who also require extracorporeal membrane oxygenation for refractory persistent pulmonary hypertension of the newborn (PPHN). However, safety data on the concomitant use of CH and extracorporeal membrane oxygenation (ECMO) are lacking.

Methods This is a single-center retrospective study of neonates ≥35 weeks' gestation with refractory PPHN who required ECMO between January 2010 and December 2020. Study groups were divided into those receiving CH/ECMO versus ECMO only. Baseline characteristics, short-term outcomes, and brain magnetic resonance imaging (MRI) data were compared.

Results A total of 36 neonates who received ECMO for refractory PPHN were included. Of these, 44.4% (n = 16) received CH/ECMO and 55.6% (n = 20) received ECMO only. Bleeding complications were more common in CH/ECMO group 50% (n = 8) versus ECMO only 15% (n = 3, p = 0.023). T1 brain MRI severity scores were higher in CH/ECMO group versus ECMO only group, however, there were no statistical difference in T2 and diffusion-weighted image scores. Functional status and survival to discharge were comparable between groups.

Conclusion In our cohort, neonates who received CH/ECMO had higher bleeding complications than ECMO only group with comparable functional status and survival at discharge.

Key Points

  • Safety data on the concomitant use of CH and ECMO are lacking in neonates.

  • In our cohort, neonates who received CH/ECMO had higher bleeding complications than ECMO only group.

  • Functional status and survival to discharge were no differences between the two groups.

Note

IRB#4 Saint Christopher's Hospital for Children/The Drexel University Institutional Review Board approved the study ID: 1810006712, with a HIPAA Waiver of Authorization


Authors' Contributions

S.J. conceptualized and designed the study, analyzed the data, drafted the initial manuscript, and reviewed and revised the manuscript. E.P. reviewed MRIs and scored the patients and reviewed the manuscript. V.Q.C. and O.M. conceptualized and designed the study, coordinated and supervised data collection, and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.




Publikationsverlauf

Eingereicht: 09. September 2021

Angenommen: 28. Februar 2022

Accepted Manuscript online:
03. März 2022

Artikel online veröffentlicht:
17. Mai 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA